|
RNF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.813030E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.503800E-03 |
| Normal-vs-Stage2 |
3.608600E-01 |
| Normal-vs-Stage3 |
8.735900E-02 |
| Normal-vs-Stage4 |
3.480000E-01 |
| Stage1-vs-Stage2 |
5.344200E-01 |
| Stage1-vs-Stage3 |
5.283100E-03 |
| Stage1-vs-Stage4 |
1.039000E-01 |
| Stage2-vs-Stage3 |
3.928200E-02 |
| Stage2-vs-Stage4 |
1.332440E-01 |
| Stage3-vs-Stage4 |
8.637400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.077950E-01 |
| Normal-vs-AfricanAmerican |
3.978600E-01 |
| Normal-vs-Asian |
6.544600E-01 |
| Caucasian-vs-AfricanAmerican |
6.602200E-01 |
| Caucasian-vs-Asian |
3.071200E-01 |
| AfricanAmerican-vs-Asian |
3.406600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.145700E-02 |
| Normal-vs-Female |
1.484010E-01 |
| Male-vs-Female |
8.578700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.446400E-01 |
| Normal-vs-Extreme_Weight |
8.277000E-03 |
| Normal-vs-Obese |
7.388400E-01 |
| Normal-vs-Extreme_Obese |
1.547900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.816840E-01 |
| Normal_Weight-vs-Obese |
8.705000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.590200E-01 |
| Extreme_Weight-vs-Obese |
7.134300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.520800E-01 |
| Obese-vs-Extreme_Obese |
1.889620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.260300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.812200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.172480E-02 |
| Normal-vs-Age(81-100Yrs) |
8.34740000000833E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.025900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.315700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.460220E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.930100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.020800E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.472500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.564360E-02 |
| Normal-VS-Type2 PRCC |
1.077810E-01 |
| Normal-VS-KIRP CIMP |
3.961500E-03 |
| Normal-VS-Unclassified PRCC |
7.603000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.783600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.50379994515271E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.748000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.059200000042E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.473800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.80450000000421E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.964200E-03 |
| Normal-vs-N1 |
1.095730E-02 |
| Normal-vs-N2 |
3.160100E-02 |
| N0-vs-N1 |
9.396400E-04 |
| N0-vs-N2 |
1.061550E-02 |
| N1-vs-N2 |
6.867600E-01 |
|
|
